R&D channel feed – Endpoints News

R&D channel feed

After filing for authorization of its Covid-19 antibody as a prophylactic, AstraZeneca pulls out new data in the treatment setting

4 years ago

Relay unrolls early data for anti-FGFR drug it thinks stand alone in terms of safety profile

4 years ago

Allogene hit with FDA clinical hold after a patient experiences 'abnormality' in CAR-T cells — shares hammered

4 years ago

Bristol Myers' TYK2 drug bombs ulcerative colitis test, but hopes are still high with psoriasis filing on deck

4 years ago

Emboldened by a positive PhIII, Novartis steers a late-stage BTK inhibitor into a pivotal MS trial

4 years ago

Sanofi, Moderna beef up the case for giving flu, Covid-19 vaccines to elderly in the same visit

4 years ago

In 'historic' public health step, WHO fully endorses GlaxoSmithKline's malaria shot

4 years ago

Takeda flashes red light on 'breakthrough' narcolepsy drug after PhII trials turned up mysterious safety signal

4 years ago

An ultra-rare disease drug missed on function but hit on survival and mortality. Is it enough for the FDA?

4 years ago

Unfazed by OS flop, Zai Lab eyes imminent China filing for MacroGenics' HER2 drug

4 years ago

A year into SPAC merger, Gemini restructures pipeline with 20% of staff, leadership on the chopping block

4 years ago

iOmx refuels with $75M+ on its search for immune checkpoint targets on tumor cells

4 years ago

Vedanta brings home a win for lead microbiome program, passing a PhII test and clinching BARDA investment

4 years ago

Enanta culls internal NASH work, betting on an out-licensing strategy in the disaster-strewn field

4 years ago

Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy

4 years ago

J&J signs on Xencor for a $100M licensing deal targeting CD20, looking to press its advantage in bispecifics

4 years ago

J&J releases the first big data cut in the RSV vaccine race, setting bar for GlaxoSmithKline and Pfizer

4 years ago

Merck claims pandemic breakthrough: Covid-19 pill reduces hospitalization and death by 50%

4 years ago

GlaxoSmithKline, Merck KGaA officially call it quits on $4B partnership for flailing cancer drug

4 years ago

Pfizer eyes potential for co-administration of its new Prevnar 20 and the seasonal flu shot

4 years ago

Editas' CRISPR-based eye therapy proves safe, but the jury's still out on whether it works

4 years ago

Safety fears force Pfizer to change pivotal DMD gene therapy trial protocol

4 years ago

Sanofi calls it quits on mRNA Covid-19 shots, scrapping vaccine from $3.2B Translate Bio buyout

4 years ago

Looking to rewrite the rules of drug licensing, startup Anji is on the hunt for 'dynamic equity' joint ventures

4 years ago

First page Previous page 157 158 159160161 162 163 Next page Last page